X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
rheumatology (47) 47
female (44) 44
index medicus (39) 39
male (38) 38
middle aged (38) 38
adult (31) 31
scleroderma (27) 27
systemic sclerosis (26) 26
arthritis (18) 18
aged (17) 17
risk factors (17) 17
severity of illness index (16) 16
scleroderma, systemic - complications (15) 15
prognosis (14) 14
rheumatoid arthritis (14) 14
clinical medicine (13) 13
eular scleroderma trials (13) 13
clinical trials (12) 12
diagnosis (12) 12
disease (12) 12
disease progression (12) 12
hypertension (12) 12
patients (12) 12
systemic scleroderma (12) 12
care and treatment (11) 11
mortality (11) 11
prevalence (11) 11
prospective studies (11) 11
radiology, nuclear medicine & medical imaging (11) 11
databases, factual (10) 10
klinikai orvostudományok (10) 10
orvostudományok (10) 10
scleroderma, systemic - physiopathology (10) 10
treatment outcome (10) 10
ultrasonography (10) 10
analysis (9) 9
fibrosis (9) 9
data bases (8) 8
studies (8) 8
survival (8) 8
cohort (7) 7
echocardiography (7) 7
klinisk medicin (7) 7
manifestations (7) 7
medical and health sciences (7) 7
medicin och hälsovetenskap (7) 7
methotrexate (7) 7
research (7) 7
retrospective studies (7) 7
rheumatoid-arthritis (7) 7
skin and connective tissue diseases (7) 7
abridged index medicus (6) 6
autoantibodies (6) 6
connective tissue diseases (6) 6
criteria (6) 6
cross-sectional studies (6) 6
integumentary system (6) 6
skin (6) 6
systemic lupus erythematosus (6) 6
time factors (6) 6
1506 (5) 5
biomarkers - blood (5) 5
clinical-trials (5) 5
complications and side effects (5) 5
double-blind (5) 5
early arthritis (5) 5
follow-up studies (5) 5
immunoglobulins (5) 5
inflammation (5) 5
involvement (5) 5
longitudinal studies (5) 5
medicine & public health (5) 5
multivariate analysis (5) 5
predictive value of tests (5) 5
research group database (5) 5
reumatologi och inflammation (5) 5
rheumatoid factor (5) 5
rheumatology and autoimmunity (5) 5
risk-factors (5) 5
scleroderma, systemic - mortality (5) 5
sex factors (5) 5
skin ulcer - etiology (5) 5
statistical analysis (5) 5
ultrasound (5) 5
adolescent (4) 4
age (4) 4
age of onset (4) 4
american-college (4) 4
antibodies (4) 4
autoantibodies - blood (4) 4
classification (4) 4
cytokines (4) 4
death (4) 4
disease-activity (4) 4
europe (4) 4
hypertension, pulmonary - etiology (4) 4
immunosuppressive agents - therapeutic use (4) 4
incidence (4) 4
interstitial lung-disease (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JCR: Journal of Clinical Rheumatology, ISSN 1076-1608, 05/2018, p. 1
Journal Article
JCR: Journal of Clinical Rheumatology, ISSN 1076-1608, 05/2018, p. 1
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2010, Volume 69, Issue 10, pp. 1809 - 1815
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
by Elhai, Muriel and Meune, Christophe and Boubaya, Marouane and Avouac, Jérôme and Hachulla, Eric and Balbir-Gurman, Alexandra and Riemekasten, Gabriela and Airò, Paolo and Joven, Beatriz and Vettori, Serena and Cozzi, Franco and Ullman, Susanne and Czirják, László and Tikly, Mohammed and Müller-Ladner, Ulf and Caramaschi, Paola and Distler, Oliver and Iannone, Florenzo and Ananieva, Lidia P and Hesselstrand, Roger and Becvar, Radim and Gabrielli, Armando and Damjanov, Nemanja and Salvador, Maria J and Riccieri, Valeria and Mihai, Carina and Szücs, Gabriella and Walker, Ulrich A and Hunzelmann, Nicolas and Martinovic, Duska and Smith, Vanessa and Müller, Carolina de Souza and Montecucco, Carlo Maurizio and Opris, Daniela and Ingegnoli, Francesca and Vlachoyiannopoulos, Panayiotis G and Stamenkovic, Bojana and Rosato, Edoardo and Heitmann, Stefan and Distler, Jörg H W and Zenone, Thierry and Seidel, Matthias and Vacca, Alessandra and Langhe, Ellen De and Novak, Srdan and Cutolo, Maurizio and Mouthon, Luc and Henes, Jörg and Chizzolini, Carlo and Mühlen, Carlos Alberto von and Solanki, Kamal and Rednic, Simona and Stamp, Lisa and Anic, Branimir and Santamaria, Vera Ortiz and Santis, Maria De and Yavuz, Sule and Sifuentes-Giraldo, Walter Alberto and Chatelus, Emmanuel and Stork, Jiri and Laar, Jacob van and Loyo, Esthela and García de la Peña Lefebvre, Paloma and Eyerich, Kilian and Cosentino, Vanesa and Alegre-Sancho, Juan Jose and Kowal-Bielecka, Otylia and Rey, Grégoire and Matucci-Cerinic, Marco and Allanore, Yannick and EUSTAR Grp and EUSTAR group and Department of Rheumatology and Lund University and Reumatologi och molekylär skelettbiologi and Lunds universitet
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2017, Volume 76, Issue 11, pp. 1897 - 1905
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2014, Volume 73, Issue Suppl 1, pp. A92 - A92
Introduction Macrophage activation syndrome is a rare and potentially life threatening condition, triggered by various events like bacterial and viral illness... 
Journal Article
Rheumatology, ISSN 1462-0324, 03/2018, Volume 57, Issue 3, pp. 441 - 450
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2014, Volume 73, Issue 3, p. A92
Journal Article